Investigating DHCR24 as a protector against cellular stress : more than just a cholesterol-synthesising enzyme

Kasz, Robert

Investigating DHCR24 as a protector against cellular stress : more than just a cholesterol-synthesising enzyme

Kasz, Robert

Permalink

Publication Type:: Thesis
Issue Date:: 2017

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download contents and abstractAdobe PDF (248.84 kB)

Adobe PDF

Download thesisAdobe PDF (2.86 MB)

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Kasz, Robert
dc.date.accessioned	2017-04-06T01:26:24Z
dc.date.available	2017-04-06T01:26:24Z
dc.date.issued	2017
dc.identifier.uri	http://hdl.handle.net/10453/90267
dc.description	University of Technology Sydney. Faculty of Science.	en_AU
dc.description.abstract	Atherosclerosis and insulin resistance are globally prevalent metabolic diseases, primarily driven by endothelial and hepatic inflammation, respectively. High density lipoprotein (HDL) reduces the inflammation in models of atherosclerosis and insulin sensitivity, and in doing so, improves these conditions. Our laboratory has demonstrated that in human coronary artery endothelial cells (HCAECs), HDL’s suppression of the inflammatory response is a gene-regulated process and that 3β-hydroxysteroid-Δ24 reductase (DHCR24) is one of the most upregulated genes by HDL. DHCR24 is a cholesterol biosynthesis enzyme however, recent work in various cell types shows DHCR24 emerging as a potent multifaceted protein protecting against cellular stress. This study commenced with confirming apolipoprotein I (apoA-I) rHDL increases DHCR24 expression in HCAECs, while revealing for the first time that HDL also increases DHCR24 expression in human hepatoma 7 (HuH7) cells. This study next questioned whether DHCR24 mimics apoA-I rHDL’s suppression of the inflammatory response in these cell types. The data presented provides proof-of-principle that DHCR24 replicates HDL’s suppression of tumour necrosis factor-alpha (TNF-α)-induced intracellular cell adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) levels in HCAECs, and interleukin 8 (IL-8) levels in HuH7 cells. Characterising DHCR24’s role was explored to learn more about how DHCR24 suppresses a TNF-α-induced inflammatory response in HCAECs and HuH7 cells. This study showed that DHCR24’s oxidoreductase region mediates DHCR24’s suppression of a TNF-α-induced inflammatory response in these cell types. This effect occurred without DHCR24 increasing cholesterol levels, despite the oxidoreductase site’s integral role in cholesterol biosynthesis. These are exciting results as they indicate that DHCR24 is more than just a cholesterol biosynthesis enzyme in HCAECs and HuH7 cells. Elucidating the mechanisms by which DHCR24 suppresses a TNF-α-induced inflammatory response in HCAECs and HuH7 cells highlighted a cell type-specific nature of DHCR24’s activity, which is in keeping with reports in the literature. In keeping with this cell type-specificity, a TNF-α-induced inflammatory response was suppressed, in part, by a decreased endoplasmic reticulum (ER) stress response in HCAECs. Interestingly, this did not occur in HuH7 cells. The work here suggests that this is attributed to the increased cholesterol content in HuH7 cells compared to HCAECs. DHCR24’s cell type-specific effects are reinforced by the cellular response of DHCR24 levels to TNF-α-activation – in HCAECs, DHCR24 levels were modestly increased; conversely in HuH7 cells, TNF-α-activation markedly decreased DHCR24 levels. Moreover, TNF-α-activation caused DHCR24’s translocation from its ER-localisation to the cytoplasm and nucleus, while in HuH7 cells, DHCR24 remained localised peri-nuclearly. This data provides novel mechanistic insight into DHCR24’s multifunctional role in two different cell types, laying the foundation for potential DHCR24-based therapeutics, and provides impetus for further investigation of DHCR24.	en_AU
dc.format	Thesis (PhD)
dc.language.iso	en_AU	en_AU
dc.relation	https://opus.lib.uts.edu.au/bitstream/10453/90267/2/02whole.pdf
dc.rights	The author owns the copyright in this thesis including all reproduction and reuse rights for the work. The work may not be altered without the permission of the copyright owner. Attribution is essential when quoting or paraphrasing from this thesis.
dc.rights	info:eu-repo/semantics/openAccess
dc.rights	au.edu.uts.lib/ppc
dc.subject	Atherosclerosis.	en
dc.subject	Insulin resistance.	en
dc.subject	Cholesterol biosynthesis enzyme DHCR24	en
dc.subject	High density lipoprotein (HDL)	en
dc.subject	HCAECs and HuH7 cells.	en
dc.title	Investigating DHCR24 as a protector against cellular stress : more than just a cholesterol-synthesising enzyme	en_AU
dc.type	Thesis	en_AU
utslib.copyright.status	open_access

Abstract:

Atherosclerosis and insulin resistance are globally prevalent metabolic diseases, primarily driven by endothelial and hepatic inflammation, respectively. High density lipoprotein (HDL) reduces the inflammation in models of atherosclerosis and insulin sensitivity, and in doing so, improves these conditions. Our laboratory has demonstrated that in human coronary artery endothelial cells (HCAECs), HDL’s suppression of the inflammatory response is a gene-regulated process and that 3β-hydroxysteroid-Δ24 reductase (DHCR24) is one of the most upregulated genes by HDL. DHCR24 is a cholesterol biosynthesis enzyme however, recent work in various cell types shows DHCR24 emerging as a potent multifaceted protein protecting against cellular stress. This study commenced with confirming apolipoprotein I (apoA-I) rHDL increases DHCR24 expression in HCAECs, while revealing for the first time that HDL also increases DHCR24 expression in human hepatoma 7 (HuH7) cells. This study next questioned whether DHCR24 mimics apoA-I rHDL’s suppression of the inflammatory response in these cell types. The data presented provides proof-of-principle that DHCR24 replicates HDL’s suppression of tumour necrosis factor-alpha (TNF-α)-induced intracellular cell adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) levels in HCAECs, and interleukin 8 (IL-8) levels in HuH7 cells. Characterising DHCR24’s role was explored to learn more about how DHCR24 suppresses a TNF-α-induced inflammatory response in HCAECs and HuH7 cells. This study showed that DHCR24’s oxidoreductase region mediates DHCR24’s suppression of a TNF-α-induced inflammatory response in these cell types. This effect occurred without DHCR24 increasing cholesterol levels, despite the oxidoreductase site’s integral role in cholesterol biosynthesis. These are exciting results as they indicate that DHCR24 is more than just a cholesterol biosynthesis enzyme in HCAECs and HuH7 cells. Elucidating the mechanisms by which DHCR24 suppresses a TNF-α-induced inflammatory response in HCAECs and HuH7 cells highlighted a cell type-specific nature of DHCR24’s activity, which is in keeping with reports in the literature. In keeping with this cell type-specificity, a TNF-α-induced inflammatory response was suppressed, in part, by a decreased endoplasmic reticulum (ER) stress response in HCAECs. Interestingly, this did not occur in HuH7 cells. The work here suggests that this is attributed to the increased cholesterol content in HuH7 cells compared to HCAECs. DHCR24’s cell type-specific effects are reinforced by the cellular response of DHCR24 levels to TNF-α-activation – in HCAECs, DHCR24 levels were modestly increased; conversely in HuH7 cells, TNF-α-activation markedly decreased DHCR24 levels. Moreover, TNF-α-activation caused DHCR24’s translocation from its ER-localisation to the cytoplasm and nucleus, while in HuH7 cells, DHCR24 remained localised peri-nuclearly. This data provides novel mechanistic insight into DHCR24’s multifunctional role in two different cell types, laying the foundation for potential DHCR24-based therapeutics, and provides impetus for further investigation of DHCR24.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/90267